Cardiac FGF23: a new player in myocardial infarction

Fibroblast Growth Factor 23 (FGF23) is a hormone involved in phosphate metabolism. It is known that FGF23 is increased in different pathologies including chronic kidney disease, heart failure or X-linked hypophosphatemia and directly correlates with negative outcome and mortality in severe diseases....

Descripción completa

Detalles Bibliográficos
Autores principales: Schumacher, David, Schuh, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Applied Systems srl 2019
Materias:
Focused Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086082/
https://www.ncbi.nlm.nih.gov/pubmed/32309615
http://dx.doi.org/10.15190/d.2019.10
_version_ 1783509058790096896
author Schumacher, David
Schuh, Alexander
author_facet Schumacher, David
Schuh, Alexander
author_sort Schumacher, David
collection PubMed
description Fibroblast Growth Factor 23 (FGF23) is a hormone involved in phosphate metabolism. It is known that FGF23 is increased in different pathologies including chronic kidney disease, heart failure or X-linked hypophosphatemia and directly correlates with negative outcome and mortality in severe diseases. However, the role of FGF23 in cardiovascular pathologies is still under debate. This review summarizes the current knowledge about the role of FGF23 in ischemic heart diseases, such as myocardial infarction.
format Online
Article
Text
id pubmed-7086082
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Applied Systems srl
record_format MEDLINE/PubMed
spelling pubmed-70860822020-04-17 Cardiac FGF23: a new player in myocardial infarction Schumacher, David Schuh, Alexander Discoveries (Craiova) Focused Review Fibroblast Growth Factor 23 (FGF23) is a hormone involved in phosphate metabolism. It is known that FGF23 is increased in different pathologies including chronic kidney disease, heart failure or X-linked hypophosphatemia and directly correlates with negative outcome and mortality in severe diseases. However, the role of FGF23 in cardiovascular pathologies is still under debate. This review summarizes the current knowledge about the role of FGF23 in ischemic heart diseases, such as myocardial infarction. Applied Systems srl 2019-09-30 /pmc/articles/PMC7086082/ /pubmed/32309615 http://dx.doi.org/10.15190/d.2019.10 Text en Copyright: © 2019, Schumacher et al. and Applied Systems http://creativecommons.org/licenses/by/4.0/ This article is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Focused Review
Schumacher, David
Schuh, Alexander
Cardiac FGF23: a new player in myocardial infarction
title Cardiac FGF23: a new player in myocardial infarction
title_full Cardiac FGF23: a new player in myocardial infarction
title_fullStr Cardiac FGF23: a new player in myocardial infarction
title_full_unstemmed Cardiac FGF23: a new player in myocardial infarction
title_short Cardiac FGF23: a new player in myocardial infarction
title_sort cardiac fgf23: a new player in myocardial infarction
topic Focused Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086082/
https://www.ncbi.nlm.nih.gov/pubmed/32309615
http://dx.doi.org/10.15190/d.2019.10
work_keys_str_mv AT schumacherdavid cardiacfgf23anewplayerinmyocardialinfarction
AT schuhalexander cardiacfgf23anewplayerinmyocardialinfarction

Ejemplares similares